Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (4G2) (MALS verified)
Product specifications
Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix®.The antibody can reacte with gE specially.
Catalog Number
VZV-M545
Product Category
Recombinant Antibodies
Material Category
Recombinant Antibodies
Storage Tempreture
-20℃
Species
Mouse
Host
HEK293
Target of Antibodies
Glycoprotein E (VZV)
Applications
ELISA,FITC
Format
Powder
Conjugate
Unconjugated

